Omnicell delivers strong fourth quarter financial results. Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA. FORT WORTH, Texas ...

Benchmark analysts maintained a Buy rating on Omnicell stock (NASDAQ:OMCL) with a consistent price target of $62.00 as the company approaches its earnings release scheduled for February 6. The target ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

The global pharmacy automation market is poised for exceptional growth, with market size projected to leap from USD 6.1 ...

Analyst Allen Lutz of Bank of America Securities maintained a Hold rating on Omnicell (OMCL – Research Report), retaining the price target of $46.00. Allen Lutz has given his Hold rating due to ...

Although this is true for many people with iron deficiency, it can be much more complicated. When determining which iron therapy—oral or intravenous (IV)—is right for you, it is important to consider ...

Sodium-cooled fast reactors using metallic-alloy fuel are attracting attention because they are inherently safe and produce more fuel than they use.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...

The rumor mill keeps churning for The Elder Scrolls IV: Oblivion remake. This time around, details about how the remake will significantly improve several gameplay systems have been unearthed.

The Elder Scrolls IV: Oblivion remake is in development, according to a plethora of rumors. And now a new rumor about the the remake has information about a potential release date. It has been 19 ...